SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
+5.52%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.07B
AUM Growth
-$308M
(-13%)
Cap. Flow
-$298M
Cap. Flow
% of AUM
-14.38%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
115
New
23
Increased
36
Reduced
14
Closed
20
Top Buys
| 1 |
Elevance Health
ELV
|
$58.1M |
| 2 |
Amazon
AMZN
|
$57.8M |
| 3 |
Yum! Brands
YUM
|
$52.3M |
| 4 |
Royalty Pharma
RPRX
|
$38.6M |
| 5 |
89bio
ETNB
|
$33.7M |
Top Sells
| 1 |
Otis Worldwide
OTIS
|
$102M |
| 2 |
Tapestry
TPR
|
$83M |
| 3 |
Las Vegas Sands
LVS
|
$78.1M |
| 4 |
Union Pacific
UNP
|
$56.3M |
| 5 |
AT&T
T
|
$54.3M |
Sector Composition
| 1 | Healthcare | 54.01% |
| 2 | Consumer Discretionary | 14.68% |
| 3 | Technology | 7.64% |
| 4 | Communication Services | 6.4% |
| 5 | Consumer Staples | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cigna
CI
$80.6B
| $1.02M | 0.04% |
+4,000
| New | +$1.02M |
|
77
Viking Therapeutics
VKTX
$2.91B
| $999K | 0.04% |
+60,000
| New | +$999K |
|
78
Waters Corp
WAT
$17.7B
| $975K | 0.04% |
3,150
+2,200
| +232% | +$681K |
|
79
Boston Scientific
BSX
$160B
| $913K | 0.04% |
18,241
+4,100
| +29% | +$205K |
|
80
Stryker
SYK
$151B
| $845K | 0.04% |
2,960
+1,300
| +78% | +$371K |
|
81
Insulet
PODD
$24.4B
| $791K | 0.03% |
+2,480
| New | +$791K |
|
82
Agilent Technologies
A
$36B
| $690K | 0.03% |
+4,990
| New | +$690K |
|
83
DexCom
DXCM
$31.4B
| $683K | 0.03% |
+5,880
| New | +$683K |
|
84
McKesson
MCK
$86.4B
| $652K | 0.03% |
1,830
-56,278
| -97% | -$20M |
|
85
Idexx Laboratories
IDXX
$51.1B
| $460K | 0.02% |
920
| – | – |
|
86
Intuitive Surgical
ISRG
$162B
| $396K | 0.02% |
1,550
| – | – |
|
87
Avantor
AVTR
$8.83B
| $326K | 0.01% |
+15,400
| New | +$326K |
|
88
United Therapeutics
UTHR
$17.4B
| $305K | 0.01% |
+1,360
| New | +$305K |
|
89
Mettler-Toledo International
MTD
$26.2B
| $251K | 0.01% |
164
| – | – |
|
90
Charles River Laboratories
CRL
$7.93B
| $204K | 0.01% |
1,010
| – | – |
|
91
Benitec Biopharma
BNTC
$365M
| $161K | 0.01% |
45,235
| – | – |
|
|
OHAAW
92
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
| $10.9K | ﹤0.01% |
72,605
| – | – |
|
93
Ventyx Biosciences
VTYX
$181M
| – | – |
-186,400
| Closed | -$6.11M |
|
94
ATAI Life Sciences
ATAI
$926M
| – | – |
-1,637,960
| Closed | -$4.36M |
|
95
Biogen
BIIB
$20.2B
| – | – |
-1,430
| Closed | -$396K |
|
96
BioMarin Pharmaceuticals
BMRN
$10.9B
| – | – |
-2,670
| Closed | -$276K |
|
97
Bristol-Myers Squibb
BMY
$95.8B
| – | – |
-3,280
| Closed | -$236K |
|
|
DFS
98
DELISTED
Discover Financial Services
DFS
| – | – |
-166,809
| Closed | -$16.3M |
|
99
Dollar General
DG
$24B
| – | – |
-173,850
| Closed | -$42.8M |
|
100
GFL Environmental
GFL
$17.8B
| – | – |
-753,818
| Closed | -$22M |
|